Zynerba Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ZYNE
CUSIP
98986X109
All holders as of
Q1 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 1 12.7 k $16.2 k
2023 Q3 46 11.5 M $14.7 M
2023 Q2 45 5.33 M $1.74 M
2023 Q1 45 6.41 M $2.75 M
2022 Q4 54 8.11 M $4.30 M
2022 Q3 66 10.9 M $7.99 M
2022 Q2 60 11.0 M $12.5 M
2022 Q1 64 13.2 M $27.5 M
2021 Q4 73 13.6 M $39.4 M
2021 Q3 67 13.5 M $57.1 M
2021 Q2 76 14.6 M $78.1 M
2021 Q1 75 9.04 M $42.0 M
2020 Q4 72 6.66 M $22.0 M
2020 Q3 74 5.46 M $18.1 M
2020 Q2 98 7.60 M $25.6 M
2020 Q1 88 9.21 M $35.3 M
2019 Q4 93 11.0 M $66.5 M
2019 Q3 97 10.5 M $79.1 M
2019 Q2 96 8.62 M $117 M
2019 Q1 70 2.31 M $12.5 M
2018 Q4 71 2.81 M $8.35 M
2018 Q3 77 2.91 M $23.7 M
2018 Q2 70 2.50 M $24.3 M
2018 Q1 71 3.00 M $26.1 M
2017 Q4 70 3.90 M $48.9 M
2017 Q3 79 3.62 M $30.5 M
2017 Q2 82 4.55 M $77.0 M
2017 Q1 76 3.57 M $71.6 M
2016 Q4 40 2.10 M $32.7 M
2016 Q3 24 2.01 M $26.3 M
2016 Q2 26 2.19 M $15.0 M
2016 Q1 30 2.76 M $26.1 M
2015 Q4 32 2.70 M $27.2 M
2015 Q3 25 2.96 M $42.4 M